Effects of Forms of Modified CIT on Upper Extremity Performance in Cerebral Palsy

Chang Gung Memorial Hospital60 enrolled

Overview

The purpose of this study will employ clinical assessment tools to examine the effects of modified constraint-induced therapy (mCIT) on the more affected upper extremity of children with cerebral palsy.

The study included threefold: (1) It will employ kinematic analysis, along with clinical assessment tools to examine the effects of mCIT on the more affected upper extremity of children with cerebral palsy with asymmetric motor impairments after treatment immediately and 1 year following. The clinical tools will include Motor Activity Log (MAL), Bruininks-Oseretsky Test of Motor Proficiency (BOTMP),Peabody-Developmental Motor Scales (PDMS-II), and Wee-FIM. (2) This study looked at the intervention impact on bimanual coordination and the less affected upper extremity. (3) It investigated the effects of forms (group vs. individual intervention) on upper extremity performance.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Cerebral Palsy

Interventions

Hospital-based mCIT restraint of the unaffected arm and practice of the affected armOTHER

the mCIT group with individualized intervention

Hospital-based mCITOTHER

the mCIT group with individualized intervention

Hospital-based TROTHER

OT or PT or therapist-based training

Eligibility

Sex: ALLMin age: 4 YearsMax age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. clinical diagnosis of spastic CP 2. age between 4 and 10 years old 3. shoulder flexion of the affected upper limb more than 90 degrees, elbow extension over 160 degrees, wrist extension to 10 degrees at least, and fingers full flexion to 10 degrees at least 4. basic balance ability: sitting on the chair without arm support; feet stay on the floor consistently; performing the affected upper limb movement without losing balance 5. ability to follow simple oral commands 6. no related musculoskeletal surgery of the affected upper limb 7. not have injected the Botox into the affected upper extremity during the past 6 months 8. no visual or auditory disability

Locations (1)

Chang Gung Memorial Hospital

Kwei-shan, Toayuan County, Taiwan

Outcomes

Primary Outcomes

Kinematic assessment

An analysis program coded by LabVIEW (National Instruments, Inc., Austin, TX) language was used to process the kinematic data. The variables of reaction time (sec), normalized movement time (sec/mm), normalized total displacement (unit), joint ranges recruitment (normalized shoulder flexion angle, normalized elbow flexion; degree/mm) angle, and normalized maximum shoulder abduction angle), and maximum shoulder and elbow cross correlation were collected.

Time frame: up to six years

Secondary Outcomes

Clinical measures at the motor quality and performance include Motor Activity Log (MAL), Bruininks-Oseretsky Test of Motor Proficiency (BOTMP), and Peabody-Developmental Motor Scales (PDMS-II)

The clinical tools used in this study measure the intervention impact on bimanual coordination and unilateral performance of upper extremity.

Time frame: up to six years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.